Mauricio G Cohen

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. doi request reprint Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience
    Mauricio G Cohen
    University of Miami Hospital, Miami, FL Electronic address
    Am Heart J 170:872-9. 2015
  2. doi request reprint First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention
    Mauricio G Cohen
    Cardiovascular Division, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Circulation 122:614-22. 2010
  3. doi request reprint Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program
    Mauricio G Cohen
    University of Miami Miller School of Medicine, FL, USA
    Circulation 121:2294-301. 2010
  4. ncbi request reprint Therapeutic goals in patients with refractory chronic angina
    Mauricio G Cohen
    Universidad de Miami, Florida, USA
    Rev Esp Cardiol 63:571-82. 2010
  5. ncbi request reprint Starting a transradial vascular access program in the cardiac catheterization laboratory
    Mauricio G Cohen
    Cardiovascular Division, Miller School of Medicine, University of Miami, University of Miami Hospital, Miami, FL 33136, USA
    J Invasive Cardiol 21:11A-17A. 2009
  6. doi request reprint The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines
    Mauricio G Cohen
    Miller School of Medicine, University of Miami, 1400 N W 12th Avenue, Room 1179, Miami, FL 33136, USA
    Am Heart J 158:263-70. 2009
  7. doi request reprint Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR
    Claudia A Martinez
    Cardiovascular Division, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida 33136, USA
    Catheter Cardiovasc Interv 82:300-11. 2013
  8. doi request reprint New-onset atrial fibrillation after aortic valve replacement: comparison of transfemoral, transapical, transaortic, and surgical approaches
    Tanyanan Tanawuttiwat
    Cardiovascular Division, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida
    J Am Coll Cardiol 63:1510-9. 2014
  9. doi request reprint Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspective
    Vikas Singh
    Cardiology, University of Miami Miller School of Medicine, Miami, Florida
    Catheter Cardiovasc Interv 85:1073-81. 2015
  10. doi request reprint Long-term outcomes associated with the transaortic approach to transcatheter Aortic valve replacement
    Joel A Lardizabal
    The Multi Disciplinary Structural Heart Disease Program of the University of Miami Miller School of Medicine, Miami, FL
    Catheter Cardiovasc Interv 85:1226-30. 2015

Collaborators

Detail Information

Publications32

  1. doi request reprint Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience
    Mauricio G Cohen
    University of Miami Hospital, Miami, FL Electronic address
    Am Heart J 170:872-9. 2015
    ..We compared the characteristics, procedures, and outcomes of high-risk PCI supported by a microaxial pump (Impella 2.5) in a multicenter registry versus the randomized PROTECT II trial (NCT00562016)...
  2. doi request reprint First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention
    Mauricio G Cohen
    Cardiovascular Division, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Circulation 122:614-22. 2010
    ..Controlled anticoagulation is possible with the REG1 system, an RNA aptamer pair comprising the direct factor IXa inhibitor RB006 and its active control agent RB007...
  3. doi request reprint Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program
    Mauricio G Cohen
    University of Miami Miller School of Medicine, FL, USA
    Circulation 121:2294-301. 2010
    ..We sought to determine whether racial/ethnic differences in evidence-based acute myocardial infarction care persist among hospitals participating in a national quality improvement program...
  4. ncbi request reprint Therapeutic goals in patients with refractory chronic angina
    Mauricio G Cohen
    Universidad de Miami, Florida, USA
    Rev Esp Cardiol 63:571-82. 2010
    ..This review provides an update on therapeutic techniques and goals, and reinforces the need for a multidisciplinary approach to the management of patients with refractory angina...
  5. ncbi request reprint Starting a transradial vascular access program in the cardiac catheterization laboratory
    Mauricio G Cohen
    Cardiovascular Division, Miller School of Medicine, University of Miami, University of Miami Hospital, Miami, FL 33136, USA
    J Invasive Cardiol 21:11A-17A. 2009
    ..To establish a transradial program and offer the benefits of this approach to most patients, a dedicated interventionalist must incorporate peers and hospital staff to create a multidisciplinary team...
  6. doi request reprint The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines
    Mauricio G Cohen
    Miller School of Medicine, University of Miami, 1400 N W 12th Avenue, Room 1179, Miami, FL 33136, USA
    Am Heart J 158:263-70. 2009
    ..We sought to identify patients with a greater probability of severe CAD to target those who could receive the greatest benefit from revascularization...
  7. doi request reprint Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR
    Claudia A Martinez
    Cardiovascular Division, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida 33136, USA
    Catheter Cardiovasc Interv 82:300-11. 2013
    ..With the expansion in the use of transcatheter valve therapies for aortic stenosis, the incidence of hemodynamically significant paravalvular regurgitation (PVR) has become a clinical challenge...
  8. doi request reprint New-onset atrial fibrillation after aortic valve replacement: comparison of transfemoral, transapical, transaortic, and surgical approaches
    Tanyanan Tanawuttiwat
    Cardiovascular Division, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida
    J Am Coll Cardiol 63:1510-9. 2014
    ....
  9. doi request reprint Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspective
    Vikas Singh
    Cardiology, University of Miami Miller School of Medicine, Miami, Florida
    Catheter Cardiovasc Interv 85:1073-81. 2015
    ..We evaluated the current trends in utilization of ASD/PFO closure in adults and investigated the effect of annual hospital volume on in-hospital outcomes...
  10. doi request reprint Long-term outcomes associated with the transaortic approach to transcatheter Aortic valve replacement
    Joel A Lardizabal
    The Multi Disciplinary Structural Heart Disease Program of the University of Miami Miller School of Medicine, Miami, FL
    Catheter Cardiovasc Interv 85:1226-30. 2015
    ..We investigated the long-term safety, efficacy and clinical outcomes associated with transaortic (TAO) transcatheter aortic valve replacement (TAVR) in the United States...
  11. doi request reprint Clinical outcomes with on-label and off-label use of the transcatheter heart valve in the United States
    Joel A Lardizabal
    The Multi Disciplinary Structural Heart Disease Program of the University of Miami, Miller School of Medicine, Miami, Florida
    Catheter Cardiovasc Interv 84:124-8. 2014
    ..We explored the efficacy, safety, and clinical consequences of on-label and off-label transcatheter aortic valve replacement (TAVR) in the real-world setting...
  12. doi request reprint ST-T wave abnormality in lead aVR and reclassification of cardiovascular risk (from the National Health and Nutrition Examination Survey-III)
    Apurva O Badheka
    Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA
    Am J Cardiol 112:805-10. 2013
    ..Adding T-wave abnormalities in lead aVR to the Framingham risk score improves model discrimination and calibration with better reclassification of intermediate-risk subjects...
  13. pmc Cerebral protection against left ventricular thrombus during transcatheter aortic valve replacement in a patient with critical aortic stenosis
    Peeyush M Grover
    Division of Cardiology, Department of Internal Medicine, University of Miami Miller School of Medicine, Miami, Florida 33136
    Tex Heart Inst J 40:477-80. 2013
    ..We present a case in which an 86-year-old man with known left ventricular thrombus underwent successful transcatheter aortic valve replacement under cerebral protection. ..
  14. doi request reprint Management Strategies and Outcomes of ST-Segment Elevation Myocardial Infarction Patients Transferred After Receiving Fibrinolytic Therapy in the United States
    Nish Patel
    Department of Cardiology, University of Miami Miller School of Medicine, Miami, Florida
    Clin Cardiol 39:9-18. 2016
    ..However, notable numbers of patients do not receive revascularization, especially patients with cardiogenic shock and following a cardiac arrest. ..
  15. doi request reprint New-onset versus prior history of atrial fibrillation: Outcomes from the AFFIRM trial
    Abdulla A Damluji
    Cardiovascular Division, University of Miami Miller School of Medicine, Miami, FL
    Am Heart J 170:156-63, 163.e1. 2015
    ..There are limited data on prognosis and outcomes of patients with new-onset atrial fibrillation (AF) compared with those with a prior history of AF...
  16. pmc The use of vascular closure devices and impact on major bleeding and net adverse clinical events (NACEs) in balloon aortic valvuloplasty: a sub-analysis of the BRAVO study
    Brian O'Neill
    Cardiovascular Division, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida
    Catheter Cardiovasc Interv 83:148-53. 2014
    ..To determine the impact of suture-mediated vascular closure devices (VCDs) on net adverse clinical events (NACEs) after balloon aortic valvuloplasty (BAV)...
  17. doi request reprint Impact of CMS coverage decision on access to transcatheter aortic valve replacement
    Brian P O'Neill
    Department of Medicine, Division of Cardiology, University of Miami Hospital, Miller School of Medicine, Miami, Florida Department of Surgery, Division of Cardiothoracic and Vascular Surgery, Cardiovascular Division, University of Miami Hospital, Miller School of Medicine, Miami, Florida Elaine and Sydney Sussman Cardiac Catheterization Laboratory, University of Miami Hospital, Miller School of Medicine, Miami, Florida
    Catheter Cardiovasc Interv 84:114-21. 2014
    ....
  18. doi request reprint Transseptal antegrade transcatheter aortic valve replacement for patients with no other access approach - a contemporary experience
    Mauricio G Cohen
    Elaine and Sydney Sussman Cardiac Catheterization Laboratory, Cardiovascular Division, Depeartment of Medicine, University of Miami Hospital, Miller School of Medicine, Miami, Florida
    Catheter Cardiovasc Interv 82:987-93. 2013
    ..To assess the feasibility and outcomes in patients undergoing transvenous transseptal (TS) transcatheter aortic valve replacement (TAVR)...
  19. doi request reprint The transaortic approach for transcatheter aortic valve replacement: initial clinical experience in the United States
    Joel A Lardizabal
    Multidisciplinary Structural Heart Disease Program at the University of Miami Miller School of Medicine, Miami, Florida, USA
    J Am Coll Cardiol 61:2341-5. 2013
    ....
  20. doi request reprint Complications and Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement With Edwards SAPIEN & SAPIEN XT Valves: A Meta-Analysis of World-Wide Studies and Registries Comparing the Transapical and Transfemoral Accesses
    Abhijit Ghatak
    University of Miami, Miller School of Medicine, Miami, Florida
    J Interv Cardiol 28:266-78. 2015
    ..We intended to perform a meta-analysis comparing the complication rates between these two approaches in studies published before and after the standardized Valve Academic Research Consortium (VARC) definitions...
  21. doi request reprint Influence of Total Coronary Occlusion on Clinical Outcomes (from the Bypass Angioplasty Revascularization Investigation 2 DiabetesTrial)
    Abdulla A Damluji
    Cardiovascular Division, Elaine and Sydney Sussman Cardiac Catheterization Laboratory, University of Miami Miller School of Medicine, Miami, Florida
    Am J Cardiol 117:1031-8. 2016
    ..However, the presence of a CTO may not increase mortality in patients treated with revascularization. Larger randomized trials are needed to evaluate the effects of revascularization on long-term survival in patients with CTO. ..
  22. doi request reprint Safety of transradial cardiac catheterization in patients with end-stage liver disease
    Evan Jacobs
    From the Cardiovascular Division, Department of Medicine, and the Elaine and Sydney Sussman Cardiac Catheterization Laboratory, University of Miami Hospital, Miller School of Medicine, Miami, Florida
    Catheter Cardiovasc Interv 83:360-6. 2014
    ..We aimed to assess the safety of transradial cardiac catheterization in patients listed for orthotopic liver transplantation...
  23. doi request reprint Aspiration Thrombectomy in Patients Undergoing Primary Angioplasty for ST Elevation Myocardial Infarction: An Updated Meta-Analysis
    Abhijit Ghatak
    Cardiovascular Division, University of Miami Miller School of Medicine, Miami, Florida
    J Interv Cardiol 28:503-13. 2015
    ....
  24. doi request reprint Comparison of outcomes of balloon aortic valvuloplasty plus percutaneous coronary intervention versus percutaneous aortic balloon valvuloplasty alone during the same hospitalization in the United States
    Vikas Singh
    Cardiovascular Division, University of Miami Miller School of Medicine, Miami, Florida
    Am J Cardiol 115:480-6. 2015
    ..Concomitant PCI and PABV during the same hospitalization are not associated with change in in-hospital mortality, complications rate, or LOS compared with PABV alone; however, it increases the cost of hospitalization. ..
  25. doi request reprint Anticoagulation for percutaneous coronary intervention: a contemporary review
    Abdulla A Damluji
    aCardiovascular Division, Department of Medicine, University of Miami, Miller School of Medicine bElaine and Sydney Sussman Cardiac Catheterization Laboratory, University of Miami Hospital, Miami, Florida, USA
    Curr Opin Cardiol 30:311-8. 2015
    ..The efficacy and safety of new anticoagulants to support PCI in different clinical scenarios have been evaluated in large clinical trials. This review summarizes the major issues and current practices for anticoagulation during PCI...
  26. doi request reprint Association between anti-human heat shock protein-60 and interleukin-2 with coronary artery calcium score
    Abdulla A Damluji
    Cardiovascular Division, University of Miami Miller School of Medicine, Miami, Florida, USA
    Heart 101:436-41. 2015
    ....
  27. doi request reprint Therapeutic goals in patients with refractory chronic angina
    Mauricio G Cohen
    Miller School of Medicine, University of Miami, Miami, Florida, USA
    Rev Esp Cardiol (Engl Ed) 63:571-82. 2010
    ..This review provides an update on therapeutic techniques and goals, and reinforces the need for a multidisciplinary approach to the management of patients with refractory angina. ..
  28. doi request reprint Reversal of end stage renal disease in patient with transcatheter aortic valve replacement
    Abdulla Damluji
    Division of Cardiology and Elaine and Sydney Sussman Cardiac Catheterization Laboratory, Miller School of Medicine, University of Miami Hospital, Miami, Florida
    Catheter Cardiovasc Interv 83:482-4. 2014
    ..We describe a case of improved kidney function in a patient with ESRD without further need for dialysis after TAVR...
  29. doi request reprint Electrocardiographic abnormalities and reclassification of cardiovascular risk: insights from NHANES-III
    Apurva O Badheka
    University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Am J Med 126:319-326.e2. 2013
    ..We aimed to assess the additive value of electrocardiogram (ECG) findings to risk prediction models for cardiovascular disease...
  30. doi request reprint Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ΙΙ study
    Mauricio G Cohen
    University of Miami Miller School of Medicine, Miami, Florida
    Catheter Cardiovasc Interv 83:1057-64. 2014
    ..To study rotational atherectomy (RA) outcomes in patients undergoing high-risk PCI randomized to receive hemodynamic support using either IABP or Impella 2.5 in the PROTECT II trial...
  31. doi request reprint Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction
    Claudia A Martinez
    Cardiovascular Division, and Elaine and Sydney Sussman Cardiac Catheterization Laboratory, University of Miami Hospital, Miller School of Medicine, Miami, Florida, USA
    Catheter Cardiovasc Interv 80:1201-9. 2012
    ..To evaluate feasibility and technical outcomes in patients with aortic stenosis (AS) who have undergone high-risk procedures with continuous flow left ventricular (LV) assist, with the Impella 2.5 system (Abiomed, Danvers, MA)...
  32. ncbi request reprint Impact of iodinated contrast injections on percent diameter coronary arterial stenosis and implications for trials of intracoronary pharmacotherapies in patients with ST-elevation myocardial infarction
    C Michael Gibson
    Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 100:13-7. 2007
    ....